L
Luis M. Montuenga
Researcher at University of Navarra
Publications - 245
Citations - 10844
Luis M. Montuenga is an academic researcher from University of Navarra. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 48, co-authored 221 publications receiving 9205 citations. Previous affiliations of Luis M. Montuenga include Chartered Institute of Management Accountants & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein
Maria Villalba,Lissett Lopez,Miriam Redrado,Tamara Ruiz,Arrate L. de Aberasturi,Nuria de la Roja,David García,Francisco Exposito,Carlos E. de Andrea,Emilio Alvarez-Fernandez,Luis M. Montuenga,Paloma Rueda,Maria Jose Rodriguez,Alfonso Calvo +13 more
TL;DR: The authors' biological tools will help the characterization of TMPRSS4 activity and protein expression, as well as the evaluation of anti-TMRSS4 drugs, which may define aggressive tumors.
Proceedings ArticleDOI
Computer Assisted Detection of Cancer Cells in Minimal Samples of Lung Cancer
Carlos Ortiz-de-Solorzano,B. Ucar-Vargas,Thomas Pengo,Isabel Zudaire,Luis M. Montuenga,A. Muoz-Barrutia +5 more
TL;DR: A quantitative, multidimensional image analysis protocol that allows preliminary immunophenotypic detection of rare cancerous candidate cells, followed by accurate three-dimensional analysis of genomic integrity, to confirm or refute the initial assessment is presented.
Book ChapterDOI
Pigment Epithelium-Derived Factor (PEDF) in the Retina
S. Patricia Becerra,Elena Alberdi,Alfredo Martínez,Luis M. Montuenga,Michel Cayouette,Claude Gravel +5 more
TL;DR: Evidence of its effects on neurons from the CNS and PNS is accumulating rapidly and supports the notion that PEDF is a multipotent neurotrophic factor that acts upon various types of neurons and from different species.
Journal ArticleDOI
Detección precoz del cáncer de pulmón por tomografía computarizada de baja dosis de radiación: resultados de una muestra de 150 individuos asintomáticos
TL;DR: Siguiendo el protocolo descrito, es posible detectar el cancer de pulmon en estadios tempranos en sujetos asintomaticos with factores of riesgo para desarrollar esta enfermedad.
Journal ArticleDOI
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
Ana Belén Herrera-Campos,Esteban Zamudio-Martínez,Daniel Delgado-Bellido,Mónica Fernández-Cortés,Luis M. Montuenga,F. Javier Oliver,Angel Garcia-Diaz +6 more
TL;DR: An overview of how hyperoxia interacts with other therapies decreasing tumor progression and the negative effects of the use of high oxygen levels is provided and the differences in the patterns of expression between a tumor-derived cell line and a nonmalignant cell line are performed.